SOLAND DANIEL B
Insider CIK 1318485 · ACAD Director · KALV Director · DBVT Director · IDRA Chief Operating Officer · VPHM VP, Chief Operating Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ACAD ACADIA PHARMACEUTICALS INC | A Award deriv | 2025-05-29 | 2025-06-02 | 13,793 | — | $0 | 13,793 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | M Exercise deriv | 2025-05-29 | 2025-06-02 | 9,387 | — | $0 | 0 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | A Award deriv | 2025-05-29 | 2025-06-02 | 8,107 | — | $0 | 8,107 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | M Exercise | 2025-05-29 | 2025-06-02 | 9,387 | — | $0 | 44,041 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | M Exercise deriv | 2024-05-29 | 2024-05-31 | 6,652 | — | $0 | 0 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | A Award deriv | 2024-05-29 | 2024-05-31 | 9,387 | — | $0 | 9,387 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | A Award deriv | 2024-05-29 | 2024-05-31 | 15,959 | — | $0 | 15,959 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | M Exercise | 2024-05-29 | 2024-05-31 | 6,652 | — | $0 | 34,654 | SEC↗ |
| DBVT DBV Technologies S.A. | P Buy | 2023-08-01 | 2023-08-03 | 15,000 | $1.62 | $24.3K | 20,000 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | A Award deriv | 2023-06-01 | 2023-06-05 | 11,045 | — | $0 | 11,045 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | A Award deriv | 2023-06-01 | 2023-06-05 | 6,652 | — | $0 | 6,652 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | M Exercise deriv | 2023-06-01 | 2023-06-05 | 8,552 | — | $0 | 0 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | M Exercise | 2023-06-01 | 2023-06-05 | 8,552 | — | $0 | 28,002 | SEC↗ |
| IDRA IDERA PHARMACEUTICALS, INC | A Award deriv | 2022-07-06 | 2022-07-07 | 66,500 | — | $0 | 66,500 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | M Exercise deriv | 2022-06-07 | 2023-06-05 | 6,391 | — | $0 | 0 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | M Exercise | 2022-06-07 | 2023-06-05 | 6,391 | — | $0 | 19,450 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | A Award deriv | 2022-06-07 | 2022-06-09 | 14,368 | — | $0 | 14,368 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | A Award deriv | 2022-06-07 | 2022-06-09 | 8,552 | — | $0 | 8,552 | SEC↗ |
| IDRA IDERA PHARMACEUTICALS, INC | A Award deriv | 2022-04-01 | 2022-04-04 | 41,500 | — | $0 | 41,500 | SEC↗ |
| IDRA IDERA PHARMACEUTICALS, INC | A Award deriv | 2022-01-24 | 2022-01-26 | 25,000 | — | $0 | 25,000 | SEC↗ |
| KALV KalVista Pharmaceuticals, | A Award deriv | 2021-09-30 | 2021-10-01 | 10,000 | — | $0 | 10,000 | SEC↗ |
| IDRA IDERA PHARMACEUTICALS, INC | A Award deriv | 2021-07-08 | 2021-07-12 | 66,500 | — | $0 | 66,500 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | M Exercise deriv | 2021-06-22 | 2023-06-05 | 3,059 | — | $0 | 0 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | M Exercise | 2021-06-22 | 2023-06-05 | 3,059 | — | $0 | 13,059 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | A Award deriv | 2021-06-22 | 2021-06-24 | 6,391 | — | $0 | 6,391 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | A Award deriv | 2021-06-22 | 2021-06-24 | 11,637 | — | $0 | 11,637 | SEC↗ |
| IDRA IDERA PHARMACEUTICALS, INC | P Buy | 2021-06-18 | 2021-06-21 | 50,000 | $1.19 | $59.5K | 78,843 | SEC↗ |
| DBVT DBV Technologies S.A. | P Buy deriv | 2021-06-10 | 2021-06-11 | 6,837 | $7.12 | $48.7K | 6,837 | SEC↗ |
| IDRA IDERA PHARMACEUTICALS, INC | P Buy | 2021-03-05 | 2021-03-05 | 10,000 | $3.90 | $39.0K | 28,843 | SEC↗ |
| IDRA IDERA PHARMACEUTICALS, INC | A Award deriv | 2021-01-04 | 2021-01-05 | 200,000 | — | $0 | 200,000 | SEC↗ |
| KALV KalVista Pharmaceuticals, | A Award deriv | 2020-10-01 | 2020-10-02 | 7,000 | — | $0 | 7,000 | SEC↗ |
| KALV KalVista Pharmaceuticals, | A Award deriv | 2020-10-01 | 2020-10-02 | 7,000 | — | $0 | 7,000 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | A Award deriv | 2020-06-23 | 2020-06-25 | 3,059 | — | $0 | 3,059 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | A Award deriv | 2020-06-23 | 2020-06-25 | 5,579 | — | $0 | 5,579 | SEC↗ |
| KALV KalVista Pharmaceuticals, | P Buy | 2019-09-27 | 2019-09-30 | 7,962 | $11.87 | $94.5K | 10,000 | SEC↗ |
| KALV KalVista Pharmaceuticals, | P Buy | 2019-09-26 | 2019-09-30 | 2,038 | $11.90 | $24.3K | 2,038 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | A Award deriv | 2019-06-26 | 2019-06-28 | 22,500 | — | $0 | 22,500 | SEC↗ |
| KALV KalVista Pharmaceuticals, | A Award deriv | 2019-04-22 | 2019-04-23 | 14,000 | — | $0 | 14,000 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | A Award deriv | 2018-06-06 | 2018-06-08 | 15,000 | — | $0 | 15,000 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | A Award deriv | 2018-06-06 | 2018-06-08 | 15,000 | — | $0 | 15,000 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | P Buy | 2018-03-02 | 2018-03-02 | 3,000 | $22.52 | $67.6K | 10,000 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | P Buy | 2018-03-01 | 2018-03-02 | 2,000 | $23.02 | $46.0K | 2,000 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | P Buy | 2018-03-01 | 2018-03-02 | 3,000 | $24.09 | $72.3K | 5,000 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | P Buy | 2018-03-01 | 2018-03-02 | 2,000 | $24.52 | $49.0K | 7,000 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | A Award deriv | 2017-07-17 | 2017-07-19 | 15,000 | — | $0 | 15,000 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | A Award deriv | 2017-06-13 | 2017-06-14 | 15,000 | — | $0 | 15,000 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | A Award deriv | 2016-06-10 | 2016-06-10 | 12,500 | — | $0 | 12,500 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | A Award deriv | 2015-06-15 | 2015-06-17 | 12,500 | — | $0 | 12,500 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | A Award deriv | 2015-03-20 | 2015-03-24 | 0 | — | $0 | 0 | SEC↗ |
| VPHM VIROPHARMA INC | D To issuer deriv | 2014-01-24 | 2014-01-28 | 48,334 | — | $0 | 0 | SEC↗ |
| VPHM VIROPHARMA INC | D To issuer deriv | 2014-01-24 | 2014-01-28 | 46,093 | — | $0 | 0 | SEC↗ |
| VPHM VIROPHARMA INC | D To issuer deriv | 2014-01-24 | 2014-01-28 | 14,999 | — | $0 | 0 | SEC↗ |
| VPHM VIROPHARMA INC | D To issuer deriv | 2014-01-24 | 2014-01-28 | 36,890 | — | $0 | 0 | SEC↗ |
| VPHM VIROPHARMA INC | D To issuer deriv | 2014-01-24 | 2014-01-28 | 54,470 | — | $0 | 0 | SEC↗ |
| VPHM VIROPHARMA INC | D To issuer deriv | 2014-01-24 | 2014-01-28 | 54,470 | — | $0 | 0 | SEC↗ |
| VPHM VIROPHARMA INC | D To issuer deriv | 2014-01-24 | 2014-01-28 | 62,500 | — | $0 | 0 | SEC↗ |
| VPHM VIROPHARMA INC | D To issuer deriv | 2014-01-24 | 2014-01-28 | 40,000 | — | $0 | 0 | SEC↗ |
| VPHM VIROPHARMA INC | D To issuer deriv | 2014-01-24 | 2014-01-28 | 33,439 | — | $0 | 0 | SEC↗ |
| VPHM VIROPHARMA INC | D To issuer deriv | 2014-01-24 | 2014-01-28 | 68,824 | — | $0 | 0 | SEC↗ |
| VPHM VIROPHARMA INC | D To issuer deriv | 2014-01-24 | 2014-01-28 | 43,355 | — | $0 | 0 | SEC↗ |
| VPHM VIROPHARMA INC | D To issuer deriv | 2014-01-24 | 2014-01-28 | 74,975 | — | $0 | 0 | SEC↗ |
| VPHM VIROPHARMA INC | D To issuer deriv | 2014-01-24 | 2014-01-28 | 67,593 | — | $0 | 0 | SEC↗ |
| VPHM VIROPHARMA INC | D To issuer deriv | 2014-01-24 | 2014-01-28 | 30,304 | — | $0 | 0 | SEC↗ |
| VPHM VIROPHARMA INC | U Tender | 2014-01-24 | 2014-01-28 | 153,332 | $50.00 | $7.67M | 0 | SEC↗ |
| VPHM VIROPHARMA INC | A Award | 2014-01-24 | 2014-01-28 | 65,818 | — | $0 | 65,818 | SEC↗ |
| VPHM VIROPHARMA INC | D To issuer | 2014-01-24 | 2014-01-28 | 65,818 | — | $0 | 0 | SEC↗ |
| VPHM VIROPHARMA INC | M Exercise deriv | 2014-01-08 | 2014-01-10 | 11,412 | — | $0 | 30,304 | SEC↗ |
| VPHM VIROPHARMA INC | M Exercise deriv | 2014-01-08 | 2014-01-10 | 5,025 | — | $0 | 74,975 | SEC↗ |
| VPHM VIROPHARMA INC | M Exercise deriv | 2014-01-08 | 2014-01-10 | 1,852 | — | $0 | 67,593 | SEC↗ |
| VPHM VIROPHARMA INC | M Exercise deriv | 2014-01-08 | 2014-01-10 | 1,000 | — | $0 | 0 | SEC↗ |
| VPHM VIROPHARMA INC | M Exercise | 2014-01-08 | 2014-01-10 | 1,852 | $13.50 | $25.0K | 153,890 | SEC↗ |
| VPHM VIROPHARMA INC | F Tax w/h | 2014-01-08 | 2014-01-10 | 558 | $49.80 | $27.8K | 153,332 | SEC↗ |
| VPHM VIROPHARMA INC | F Tax w/h | 2014-01-08 | 2014-01-10 | 155 | $49.80 | $7.7K | 139,195 | SEC↗ |
| VPHM VIROPHARMA INC | F Tax w/h | 2014-01-08 | 2014-01-10 | 1,175 | $49.80 | $58.5K | 152,038 | SEC↗ |
| VPHM VIROPHARMA INC | M Exercise | 2014-01-08 | 2014-01-10 | 5,025 | $9.99 | $50.2K | 153,213 | SEC↗ |
| VPHM VIROPHARMA INC | F Tax w/h | 2014-01-08 | 2014-01-10 | 2,419 | $49.80 | $120.5K | 148,188 | SEC↗ |
| VPHM VIROPHARMA INC | M Exercise | 2014-01-08 | 2014-01-10 | 11,412 | $8.86 | $101.1K | 150,607 | SEC↗ |
| VPHM VIROPHARMA INC | M Exercise | 2014-01-08 | 2014-01-10 | 1,000 | $5.91 | $5.9K | 139,350 | SEC↗ |
| VPHM VIROPHARMA INC | M Exercise deriv | 2013-12-27 | 2013-12-31 | 11,500 | — | $0 | 1,000 | SEC↗ |
| VPHM VIROPHARMA INC | F Tax w/h | 2013-12-27 | 2013-12-31 | 1,809 | $49.86 | $90.2K | 138,350 | SEC↗ |
| VPHM VIROPHARMA INC | M Exercise | 2013-12-27 | 2013-12-31 | 11,500 | $5.91 | $68.0K | 140,159 | SEC↗ |
| VPHM VIROPHARMA INC | M Exercise deriv | 2013-12-18 | 2013-12-20 | 83,284 | — | $0 | 41,716 | SEC↗ |
| VPHM VIROPHARMA INC | M Exercise deriv | 2013-12-18 | 2013-12-20 | 37,500 | — | $0 | 12,500 | SEC↗ |
| VPHM VIROPHARMA INC | M Exercise | 2013-12-18 | 2013-12-20 | 37,500 | $5.91 | $221.6K | 109,458 | SEC↗ |
| VPHM VIROPHARMA INC | F Tax w/h | 2013-12-18 | 2013-12-20 | 17,529 | $49.74 | $871.9K | 91,929 | SEC↗ |
| VPHM VIROPHARMA INC | M Exercise | 2013-12-18 | 2013-12-20 | 83,284 | $8.86 | $737.9K | 175,213 | SEC↗ |
| VPHM VIROPHARMA INC | F Tax w/h | 2013-12-18 | 2013-12-20 | 46,554 | $49.74 | $2.32M | 128,659 | SEC↗ |
| VPHM VIROPHARMA INC | A Award deriv | 2013-06-10 | 2013-06-12 | 43,355 | — | $0 | 43,355 | SEC↗ |
| VPHM VIROPHARMA INC | A Award deriv | 2013-01-03 | 2013-01-07 | 46,093 | — | $0 | 46,093 | SEC↗ |
| VPHM VIROPHARMA INC | A Award deriv | 2012-06-04 | 2012-06-06 | 48,334 | — | $0 | 48,334 | SEC↗ |
| VPHM VIROPHARMA INC | M Exercise deriv | 2012-03-09 | 2012-03-13 | 5,555 | — | $0 | 69,445 | SEC↗ |
| VPHM VIROPHARMA INC | M Exercise deriv | 2012-03-09 | 2012-03-13 | 6,561 | — | $0 | 33,439 | SEC↗ |
| VPHM VIROPHARMA INC | M Exercise deriv | 2012-03-09 | 2012-03-13 | 5,001 | — | $0 | 14,999 | SEC↗ |
| VPHM VIROPHARMA INC | M Exercise deriv | 2012-03-09 | 2012-03-13 | 31,176 | — | $0 | 68,824 | SEC↗ |
| VPHM VIROPHARMA INC | F Tax w/h | 2012-03-09 | 2012-03-13 | 21,071 | $29.65 | $624.8K | 70,103 | SEC↗ |
| VPHM VIROPHARMA INC | M Exercise | 2012-03-09 | 2012-03-13 | 6,561 | $15.24 | $100.0K | 49,442 | SEC↗ |
| VPHM VIROPHARMA INC | M Exercise | 2012-03-09 | 2012-03-13 | 5,001 | $9.96 | $49.8K | 54,443 | SEC↗ |
| VPHM VIROPHARMA INC | M Exercise | 2012-03-09 | 2012-03-13 | 5,555 | $13.50 | $75.0K | 59,998 | SEC↗ |
| VPHM VIROPHARMA INC | M Exercise | 2012-03-09 | 2012-03-13 | 31,176 | $12.83 | $400.0K | 91,174 | SEC↗ |
| VPHM VIROPHARMA INC | S Sale | 2012-03-01 | 2012-03-06 | 30,000 | $32.99 | $989.7K | 42,881 | SEC↗ |
| VPHM VIROPHARMA INC | A Award deriv | 2012-01-05 | 2012-01-06 | 36,890 | — | $0 | 36,890 | SEC↗ |